Viewing Study NCT01582334


Ignite Creation Date: 2025-12-25 @ 2:35 AM
Ignite Modification Date: 2026-02-11 @ 4:20 AM
Study NCT ID: NCT01582334
Status: COMPLETED
Last Update Posted: 2017-12-26
First Post: 2012-04-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina
Sponsor: Merck KGaA, Darmstadt, Germany
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EMR200104-532
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View